Latest Insider Transactions at Ionis Pharmaceuticals Inc (IONS)
This section provides a real-time view of insider transactions for Ionis Pharmaceuticals Inc (IONS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of IONIS PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of IONIS PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 31
2021
|
Richard S Geary EVP, Chief Development Officer |
BUY
Other acquisition or disposition
|
Direct |
46
+0.11%
|
$1,518
$33.8 P/Share
|
|
Jul 15
2021
|
Spencer R Berthelsen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,666
+1.95%
|
-
|
|
Jul 15
2021
|
Michael R Hayden Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,111
+22.92%
|
-
|
|
Jul 15
2021
|
Joan E Herman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,111
+18.64%
|
-
|
|
Jul 15
2021
|
Joseph Klein Iii Director |
SELL
Open market or private sale
|
Direct |
4,334
-19.3%
|
$151,690
$35.3 P/Share
|
|
Jul 15
2021
|
Joseph Klein Iii Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,666
+9.13%
|
-
|
|
Jul 15
2021
|
Joseph Loscalzo Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,666
+7.95%
|
-
|
|
Jul 15
2021
|
Frederick T Muto Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,666
+5.2%
|
-
|
|
Jul 15
2021
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+3.54%
|
-
|
|
Jul 15
2021
|
Peter N Reikes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,111
+22.92%
|
-
|
|
Jul 15
2021
|
Joseph H Wender Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
8,666
+2.2%
|
-
|
|
Jun 23
2021
|
Spencer R Berthelsen Director |
SELL
Open market or private sale
|
Direct |
15,000
-12.93%
|
$555,000
$37.74 P/Share
|
|
Jun 23
2021
|
Spencer R Berthelsen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+11.45%
|
$135,000
$9.3 P/Share
|
|
Jun 15
2021
|
Frederick T Muto Director |
SELL
Open market or private sale
|
Direct |
15,000
-13.63%
|
$540,000
$36.63 P/Share
|
|
Jun 15
2021
|
Frederick T Muto Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+12.0%
|
$135,000
$9.3 P/Share
|
|
Jun 10
2021
|
Joan E Herman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,555
+28.57%
|
-
|
|
Apr 15
2021
|
Onaiza Cadoret Manier EVP, Chf GL Pdt Str & Oper Ofc |
SELL
Payment of exercise price or tax liability
|
Direct |
1,960
-31.82%
|
$80,360
$41.03 P/Share
|
|
Apr 15
2021
|
Onaiza Cadoret Manier EVP, Chf GL Pdt Str & Oper Ofc |
BUY
Exercise of conversion of derivative security
|
Direct |
5,667
+47.92%
|
-
|
|
Mar 01
2021
|
Brett P Monia Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
236
-0.47%
|
$12,744
$54.27 P/Share
|
|
Feb 26
2021
|
Brett P Monia Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
247
+0.49%
|
$10,868
$44.54 P/Share
|
|
Feb 26
2021
|
C Frank Bennett EVP, Chief Scientific Officer |
BUY
Other acquisition or disposition
|
Direct |
112
+0.26%
|
$4,928
$44.54 P/Share
|
|
Feb 26
2021
|
Onaiza Cadoret Manier EVP, Chf GL Pdt Str & Oper Ofc |
BUY
Other acquisition or disposition
|
Direct |
492
+50.0%
|
$21,648
$44.54 P/Share
|
|
Feb 26
2021
|
Richard S Geary EVP, Chief Development Officer |
BUY
Other acquisition or disposition
|
Direct |
414
+0.98%
|
$18,216
$44.54 P/Share
|
|
Feb 26
2021
|
Elizabeth L Hougen EVP, Finance & CFO |
BUY
Other acquisition or disposition
|
Direct |
116
+0.27%
|
$5,104
$44.54 P/Share
|
|
Feb 26
2021
|
Patrick R. O'Neil EVP CLO & General Counsel |
BUY
Other acquisition or disposition
|
Direct |
197
+0.73%
|
$8,668
$44.54 P/Share
|
|
Feb 26
2021
|
Eric Swayze EVP Research |
BUY
Other acquisition or disposition
|
Direct |
460
+3.91%
|
$20,240
$44.54 P/Share
|
|
Jan 28
2021
|
Brett P Monia Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,306
-2.54%
|
$78,360
$60.69 P/Share
|
|
Jan 28
2021
|
Brett P Monia Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,634
+4.87%
|
-
|
|
Jan 26
2021
|
Stanley T Crooke Exec Chairman of the Board |
SELL
Open market or private sale
|
Direct |
28,333
-93.34%
|
$1,784,979
$63.74 P/Share
|
|
Jan 25
2021
|
Patrick R. O'Neil EVP CLO & General Counsel |
SELL
Open market or private sale
|
Direct |
5,324
-16.73%
|
$335,412
$63.5 P/Share
|
|
Jan 22
2021
|
Stanley T Crooke Exec Chairman of the Board |
SELL
Open market or private sale
|
Indirect |
40,000
-7.49%
|
$2,440,000
$61.67 P/Share
|
|
Jan 21
2021
|
Stanley T Crooke Exec Chairman of the Board |
SELL
Open market or private sale
|
Indirect |
35,000
-3.12%
|
$2,135,000
$61.09 P/Share
|
|
Jan 15
2021
|
Eric Swayze EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
3,216
-22.89%
|
$196,176
$61.28 P/Share
|
|
Jan 15
2021
|
Eric Swayze EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
8,944
+38.9%
|
-
|
|
Jan 15
2021
|
Eugene Schneider EVP, Chf Clinical Develop Ofcr |
SELL
Payment of exercise price or tax liability
|
Direct |
2,718
-28.25%
|
$165,798
$61.28 P/Share
|
|
Jan 15
2021
|
Eugene Schneider EVP, Chf Clinical Develop Ofcr |
BUY
Exercise of conversion of derivative security
|
Direct |
7,503
+43.82%
|
-
|
|
Jan 15
2021
|
B Lynne Parshall Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,741
-4.02%
|
$167,201
$61.28 P/Share
|
|
Jan 15
2021
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,655
+13.53%
|
-
|
|
Jan 15
2021
|
Patrick R. O'Neil EVP CLO & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
5,856
-15.54%
|
$357,216
$61.28 P/Share
|
|
Jan 15
2021
|
Patrick R. O'Neil EVP CLO & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
16,504
+30.46%
|
-
|
|
Jan 15
2021
|
Brett P Monia Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,927
-23.43%
|
$910,547
$61.28 P/Share
|
|
Jan 15
2021
|
Brett P Monia Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
34,823
+35.34%
|
-
|
|
Jan 15
2021
|
Elizabeth L Hougen EVP, Finance & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,175
-12.44%
|
$376,675
$61.28 P/Share
|
|
Jan 15
2021
|
Elizabeth L Hougen EVP, Finance & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,151
+25.68%
|
-
|
|
Jan 15
2021
|
Richard S Geary EVP, Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,398
-13.36%
|
$390,278
$61.28 P/Share
|
|
Jan 15
2021
|
Richard S Geary EVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,598
+26.87%
|
-
|
|
Jan 15
2021
|
C Frank Bennett EVP, Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,488
-11.43%
|
$334,768
$61.28 P/Share
|
|
Jan 15
2021
|
C Frank Bennett EVP, Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,520
+24.43%
|
-
|
|
Jan 15
2021
|
Stanley T Crooke Exec Chairman of the Board |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,434
-31.55%
|
$87,474
$61.28 P/Share
|
|
Jan 15
2021
|
Stanley T Crooke Exec Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,371
+49.02%
|
-
|